Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-02 @ 2:51 AM
Study NCT ID:
NCT02706951
Status:
COMPLETED
Last Update Posted:
2024-01-30
First Post:
2016-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-18
First Submit QC Date:
None
Study First Post Date:
2016-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-13
Results First Submit QC Date:
None
Results First Post Date:
2019-10-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-09-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-01-03
Last Update Post Date:
2024-01-30
Last Update Post Date Type:
ACTUAL